Promising candidates from drug clinical trials: Implications for clinical treatment of Alzheimer's disease in China

Alzheimer's disease is the most common neurodegenerative disease. Prior to 2017, National Medical Products Administration approved only four drugs to treat Alzheimer's disease, including three cholinesterase inhibitors and one N-methyl-D-aspartate receptor antagonist. We queried ClinicalTr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yuxia, Yu, Feng, Lyu, Yi, Lu, Xianfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706102/
https://www.ncbi.nlm.nih.gov/pubmed/36457865
http://dx.doi.org/10.3389/fneur.2022.1034243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706102/
https://www.ncbi.nlm.nih.gov/pubmed/36457865
http://dx.doi.org/10.3389/fneur.2022.1034243

Ejemplares similares